Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Asahi Kasei Corp. : Construction of new acetonitrile plant in Korea

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/06/2012 | 04:35am CEST

Asahi Kasei Chemicals Corp.

Asahi Kasei Chemicals has finalized a decision to construct a new acetonitrile plant in Korea. The plant will have a production capacity of 11,000 tons per year, and start-up is scheduled for January 2014. Having a second production base for acetonitrile, in addition to its Japanese base, will enable Asahi Kasei Chemicals to assure a reliable supply of acetonitrile as demand continues to grow rapidly worldwide.

Acetonitrile is produced by refining the crude acetonitrile obtained as a byproduct of acrylonitrile (AN). It is mainly used as a solvent in the manufacture of pharmaceuticals, with other notable uses including as analytical reagent and in the field of agrichemicals. With an acetonitrile plant in Kawasaki, Kanagawa, Japan, having a production capacity of 14,000 tons per year, Asahi Kasei Chemicals is a major supplier to markets in Asia and Europe as well as Japan. Strong growth in demand for acetonitrile is forecasted, particularly for use in the field of pharmaceutical manufacture. Asahi Kasei Chemicals had therefore been examining how best to increase production capacity and ensure reliable supply as markets continue to grow.

A decision was made to construct a new acetonitrile plant at Tong Suh Petrochemical Corp., Ltd., an Asahi Kasei Group company in Korea, which is currently constructing a new AN plant in Ulsan with startup scheduled for January 2013. The acetonitrile plant in Korea will utilize crude acetonitrile byproduct from the AN plants in Korea.

Having two production bases for acetonitrile, in Japan and Korea, will enable Asahi Kasei Chemicals to provide reliable supply to meet growing demand in the pharmaceutical industry especially in India and China.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
03/30 ASAHI KASEI : Capacity expansion for Hipore™ LIB separator
03/29 ASAHI KASEI CORP : ex-dividend day for final dividend
03/23 ASAHI KASEI : Patent Application Titled "Protein Adsorbent" Published Online (US..
03/23 ASAHI KASEI : Recent Research from Asahi Kasei Pharma Corporation Highlight Find..
03/16 ASAHI KASEI : Patent Issued for Diagnostic Method and Diagnostic Device for a Sl..
03/15 BOSTON SCIENTIFIC : Global Defibrillator Market 2017 – Defibtech, Boston S..
03/12 ASAHI KASEI : ZOLL receives FDA approval for new device
03/10 ASAHI KASEI : Patent Issued for Magnetic Field Measuring Device (USPTO 9581426)
03/09 ASAHI KASEI : Change in Representative Directors
03/08 ASAHI KASEI : Home Order Trends – February 2017
More news
Sector news : Commodity Chemicals - NEC
03/30DJLINDE : Praxair Merger Faces Opposition From Labor Representatives
03/29 OTHER AKZO SHAREHOLDERS ALSO WANT TA : Elliott Advisors
03/29 OTHER AKZO SHAREHOLDERS ALSO WANT TA : Elliott Advisors
03/29 AKZO NOBEL : Other Akzo shareholders also want talks with PPG - Elliott Advisors
03/28DJAKZO NOBEL : to Detail Plan to Separate Its Specialty Chemicals Business -- Upda..
More sector news : Commodity Chemicals - NEC
News from SeekingAlpha
01/19 Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery
2016 JAPANESE EQUITIES : False Dawn Or Rising Star?
2016 GMO International Active EAFE Strategy Q3 2016 Commentary
2016 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
2016 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
Advertisement
Financials ( JPY)
Sales 2017 1 872 395 M
EBIT 2017 -
Net income 2017 105 736 M
Debt 2017 240 577 M
Yield 2017 1,90%
P/E ratio 2017 14,57
P/E ratio 2018 14,06
EV / Sales 2017 0,95x
EV / Sales 2018 0,88x
Capitalization 1 544 982 M
More Financials
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Full-screen chart
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 080  JPY
Spread / Average Target -2,0%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP8.94%13 891
AIR LIQUIDE1.33%44 778
SHIN-ETSU CHEMICAL CO ..6.76%38 163
LYONDELLBASELL INDUSTR..5.77%36 522
PRAXAIR, INC.1.02%33 771
AIR PRODUCTS & CHEMICA..-4.90%29 762
More Results